InvestorsHub Logo

HDGabor

07/10/19 6:02 PM

#200940 RE: MedResCollab #200932

M-

Why anyone would want to sit passively in a long position here is beyond us. Especially after this run up. All you are possibly missing by selling until early-mid September are negative catalysts. In fact, the only positions that make sense until then are short leveraged

A few reason:
(i) no Adcom communication (or lack of any info re. AdCom) in the mid-cycle communication … "due" by 7/12
(ii) ICER draft report (7/24) support the use of Vascepa
(iii) earlier approval by the FDA

(i) and (ii) have a high probability … the (iii) could happen (by any day after August 1).

Best,
G